This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Hemangioma, Cavernous, Central Nervous System
Information about Hemangioma, Cavernous, Central Nervous System: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Hemangioma, Cavernous, Central Nervous System
Most recent studies have shown that Hemangioma, Cavernous, Central Nervous System shares some biological mechanisms with angioma-cavernous, brain-neoplasms, brain-stem-neoplasms, cavernous-hemangioma-of-brain, central-nervous-system-neoplasms, cerebral-hemorrhage, epilepsy, headache, hemangioma, hemangioma-cavernous, hematoma, hemorrhage, intracranial-arteriovenous-malformation, intracranial-hemorrhages, malnutrition, neoplasms, nervousness, spinal-cord-neoplasms, vascular-anomaly.
Among the many pathways, these few ones have gauged particular interests from scientists studying Hemangioma, Cavernous, Central Nervous System, and have been seen in publications frequently: Angiogenesis, Brain Development, Cell Adhesion, Cell Death, Cell Migration, Cell Proliferation, Coagulation, Endothelial Cell Proliferation, Gene Silencing, Immune Response, Localization, Ossification, Pathogenesis, Programmed Cell Death, Reflex, Segmentation, Transposition, Tube Formation, Vasculogenesis
Quite a number of genes have been found to play important roles in Hemangioma, Cavernous, Central Nervous System, such as ACAT1, ACE, AKT1, C4B, CCM2, ITGB1BP1, KRIT1, MAPK1, NLRP5, PCNA, PDCD10, PTPN13, RABGEF1, RAP1A, RHOA, SLC25A5, STK25, TERF2IP, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.